Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01699906 · ClinicalTrials.gov registry record · NA
Diet Induced Weight Loss to Reduce Inflammation in Obese Women
A NA study, sponsored by Rockefeller University.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT01699906 is a NA study that has completed, run by Rockefeller University. The registered enrollment target is 22 participants.
The verdict
NCT01699906, a NA study, has completed, sponsored by Rockefeller University.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
Breast cancer is one of the most frequently seen cancers in the United States. It occurs at all ages but is particularly common in post menopausal women. Obesity increases the risk of breast cancer and colon cancer among others, and when cancer develops increases the risk of spread and death. Inflammation of fat tissue, the coronary blood vessels and the liver are also seen with obesity. Animal experiments have shown the inflammation in fat tissue increases the production of estrogen. Thus, reducing inflammation in fat tissue might lower estrogen levels and reduce the risk of breast cancer in obese women as well as the spread of other cancers in the body. Weight reduction in obesity has been shown in epidemiology studies to lower the risk of colon cancer and in obese women to lower the risk of breast cancer. However, how that occurs and how much weight loss is necessary is not known. In mice, calorie restriction in obese animals has been shown to reduce inflammation in fat tissue and the breast. In other studies, calorie reduction has been shown to lower the development of cancer. In addition, we really do not know what starts the whole inflammation process. One good possibility is that immune factors that tend to reduce inflammation are less in obesity. We have shown this in the colon and this also has been suggested as occurring in fat stores.
Interventions
- OTHER Diet regimen to induce weight loss
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2012-09 |
| Est. Completion | 2014-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01699906
The ClinicalTrials.gov registry entry for NCT01699906 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diet regimen to induce weight loss is the first listed.
NCT01699906 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01699906 about?
NCT01699906 is a clinical study titled "Diet Induced Weight Loss to Reduce Inflammation in Obese Women". Breast cancer is one of the most frequently seen cancers in the United States. It occurs at all ages but is particularly common in post menopausal women. Obesity increases the risk of breast cancer and colon cancer among others, and when cancer develops increases the risk of spread and death. Inflam...
What is the current status of trial NCT01699906?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2012-09. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01699906?
The interventions under investigation include: Diet regimen to induce weight loss (OTHER).
Who is sponsoring clinical trial NCT01699906?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.